Pharmaceutical Regulatory Affairs: Open Access

Titel Veröffentlichungsdatum Sprache Zitate
Historical Overview of Pharmaceutical Industry and Drug Regulatory Affairs2012/01/01
Gas Plasma Exposure to Bacterial Spore, Endotoxin and Prion2015/01/01
Research into Materials Used in Abdominal Wall Repair2015/01/01
Sterilization Validation of Gas Plasma Exposure Based on ISO Documents(Mainly ISO TC 198 And 194 Documents)2015/01/01
Current Regulatory Scenario for Conducting Clinical Trials in India2015/01/01
Regulations in Development of Biosimilars2015/01/01
Validation Study of Nitrogen Gas Plasma Exposure Based on ISO Documents (Mainly ISO TC 198 and 194 Documents)2015/01/01
Human Platelet Concentrates and Derivatives Preparation Issues Pretransfusion2015/01/01
Performance of Qualification of Ethylene Oxide Gas Sterilization Process2015/01/01
Multicentre Clinical Trial Monitoring2012/01/01
Cancer Tragedy in this Century and the Role of OMICS Group Open Access Journals in Overcoming this Matter2012/01/01
Canada's Natural Health Products: A Regulatory Overview2016/01/01
Organophosphate (OP) Poisoning Case Report by the Ingestion of a Potential Lethal Dose; its Management and Appropriate Protocol2016/01/01
Second Medical use Patents for Medicinal Products in the EU: When is Being Skinny not enough?2016/01/01
Nationwide Registries Associated with Cardiovascular Medical Devices in Japan2016/01/01
Ensure Quality Assurance for Companies and Institutions2016/01/01
Mucoadhesive Micro and Nanoparticles for Oral Controlled Drug Delivery System for Prolongation of Gastric Residence and Its Application2012/01/01
Science Requires Coexisting of Opposite Opinions:“One Country, Two Systems”2012/01/01
Why the Study of Cancer Needs a Systemic Approach?2012/01/01
The Democratization of Dental Implants for General Dentistry2012/01/01
Responsibility of Regulatory Affairs in Pharmaceutical Industry2012/01/01
Collaboration and Socialization of Health Care Professionals to Improve the Clinical and Pharmaceutical Patients Care2016/01/01
Brazilian Regulation in Pharmacovigilance: A Review2016/01/01
De-convoluting the European Commission Cosmos2012/01/01
Management of Diabetes in Africa: The Role of Traditional Medicines2012/01/01
Cutting Edge of Pharmaceutical Nanotechnology2012/01/01
Assessment of Dependence Liability of New Molecular Entities under the Current FDA Draft Guidance Document: Seeking Best Practices2016/01/01
Emergence in the Lipid-Based Nanostructured Systems for Optimizing Oral Delivery of Drugs2016/01/01
Negative Effects of Addiction2012/01/01
Essential consensus and scientific definitions for advancement in pharmaceutical regulatory affairs2015/01/01